2008年度買い上げ違法ドラッグ製品から検出された新規流通デザイナードラッグの同定

書誌事項

タイトル別名
  • Analysis of Newly Distributed Designer Drugs Detected in the Products Purchased in Fiscal Year 2008
  • 2008ネンド カイアゲ イホウ ドラッグ セイヒン カラ ケンシュツ サレタ シンキ リュウツウ デザイナードラッグ ノ ドウテイ

この論文をさがす

抄録

  Thirty-two psychotropic substances were listed as designated substances (Shitei-Yakubutsu, 31 compounds and 1 plant) in Japan by the Pharmaceutical Affairs Law in April 2007 for preventing the abuse of these substances. Subsequently, other psychoactive compounds were also added to this category, 40 substances (classified as 12 tryptamines, 17 phenethylamines, 3 piperazines, 6 alkyl nitrites, 1 diterpene and 1 plant) are controlled as designated substances as of July 2009. However, new designer drugs are still distributed in illegal drug market according to the results of our annual survey. This study presents the analysis of four newly distributed designer drugs detected from two products, which were purchased from October 2008 to February 2009 in Japan. As the results of NMR, GC-MS and LC-MS analyses, three phenethylamine derivertives, 1-(2-fluorophenyl)-N-methylpropan-2-amine (N-Me-2-FMP), 1-(2,5-dimethoxy-4-isopropylsulfanylphenyl)propan-2-amine (ALEPH-4) and 1-(2,5-dimethoxy-4-nitrophenyl)propan-2-amine (DON) and a tryptamine derivative, N-ethyl-5-methoxy-N-propyltryptamine (5-MeO-EPT), were detected. N-Me-2-FMP and 5-MeO-EPT were newly identified in this study. Additionally, ALEPH-4 and DON were found as novel illegal drugs distributed in Japan.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 130 (2), 263-270, 2010-02-01

    公益社団法人 日本薬学会

被引用文献 (9)*注記

もっと見る

参考文献 (15)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ